Pharma Journalist -

SMi Group reports: Pain Therapeutics conference will reconvene on 11th and 12 May by remote access. Regarding concerns over COVID-19 SMi’s 20th Annual Pain Therapeutics…
Read More...

AstraZeneca has completed the previously communicated agreement to sublicense its global rights to Movantik (naloxegol), excluding Europe, Canada and Israel, to RedHill Biopharma…
Read More...

Neurimmune AG and Ethris GmbH announced an exclusive partnership to develop mRNA-encoded, neutralizing anti-SARS-CoV-2 antibodies administered by inhalation for the treatment of…
Read More...

Arena International announced today that the Temperature Controlled Logistics in Biopharmaceuticals Conference (https://arena-international.com/pharmatempusa/) will be held as a Virtual…
Read More...

Sorrento Therapeutics, Inc. announced it has initiated the next phase of its collaboration with Celularity, Inc., a Warren, New Jersey, based clinical-stage cell therapeutics company…
Read More...

Novartis announced plans to initiate a Phase III clinical trial in collaboration with Incyte to evaluate the use of Jakavi (ruxolitinib) for treatment of a type of severe immune…
Read More...

Kite, a Gilead Company and Teneobio, Inc. announced the companies have entered into a license and collaboration agreement through which Kite will receive exclusive rights to certain…
Read More...

Novartis announced the mutual agreement with Aurobindo Pharma USA Inc. to terminate the agreement to sell the Sandoz US generic oral solids and dermatology businesses to Aurobindo…
Read More...

Fate Therapeutics, Inc. announced a global collaboration and option agreement with Janssen Biotech, Inc. (Janssen), one of the Janssen Pharmaceutical Companies of Johnson & Johnson.…
Read More...

ImmunityBio, Inc., a privately held immunotherapy company within the NantWorks ecosystem of companies, announced it is collaborating with Microsoft to leverage the company’s Azure…
Read More...